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Abstract
Mass spectrometry (MS) has become the foremost detection method in protein analysis. 
In order to realize the sensitivity levels mass spectrometers are capable of, analytes must 
be purified from other components in the sample. This has become especially important 
with the trend toward miniaturization and development of microfluidic and lab-on-a-chip 
devices. In this thesis two sample preparation techniques for application in studying 
phosphorylated peptides were investigated using capillary electrophoresis. The first 
technique investigated a novel approach of integrating sample purification and 
preconcentration with the coupling of selective sample injection, based on the isoelectric 
point of the analytes, and enrichment using a pH junction. The integration of the two 
methods was successful. The second technique investigated miniaturization of a methyl 
esterification reaction. This reaction is commonly used when studying phosphorylated 
peptides to reduce the non-specific binding of acidic peptides during affinity 
chromatography. The reaction conditions were optimized and performed inside a 
capillary.
Keywords: capillary electrophoresis, sample preparation, isoelectric point, 
preconcentration, phospholipid coating, miniaturization, methyl esterification, protein 
phosphorylation
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Chapter 1: Introduction to Capillary Electrophoresis and Mass
Spectrometry in Protein Analysis
2
1.1 Protein Analysis
The sequencing of the genome has led to the study of other ‘omics’ fields due, in 
part, to the application of techniques developed for genomics to these other ‘omics’ 
fields. One of the most studied ‘omics’ fields is described by the set of proteins coded by 
the genome, called the proteome, with the study of the proteome called proteomics [2], 
Studying the proteome of an organism is a much more difficult and complex task than 
studying the genome because the proteome is dynamic unlike the genome which is static. 
There is a large range in protein expression levels (i.e. concentration of proteins). 
Additionally, the expression level of a protein can vary greatly depending on stressors 
(ex: temperature changes, infection, UV radiation, etc) [3, 4], In addition, once proteins 
are synthesized they can be modified in many different ways [5], Sequencing and 
understanding the proteome holds the key to individual protein function, unraveling 
molecular pathways involved in cellular responses, as well as identifying biomarkers for 
disease [6-10].
One of the first methods used to sequence proteins was the Edman degradation 
[11, 12]. Briefly, this method involves the cleavage of the N-terminal amino acid. The 
newly cleaved amino acid is loaded onto a chromatography column and then identified by 
comparing the retention time to standard amino acids. This method is repeated until the 
entire protein is sequenced. Even though this method is quite simple, there are several 
drawbacks: it is very time consuming, sequencing of proteins larger than 50 amino acids 
is difficult, the protein sample must be very pure, and if the N-terminus is modified the 
procedure will not work [13].
Advances in mass spectrometry (MS) over the last twenty-five years have made 
this the detection method of choice for proteomics research. The main reason for this is 
the development of two ionization techniques: electrospray ionization (ESI) [14-16] and 
matrix assisted laser desorption/ionization (MALDI) [17]. These ionization mechanisms 
are considered ‘soft’ because they enable the formation of intact gas-phase ions without 
fragmentation of the analyte. This allows for the collection of accurate mass information 
on proteins and peptides. Earlier ionization mechanisms such as electron impact (El) and 
fast atom bombardment (FAB) are considered ‘hard’ ionization mechanisms and result in 
extensive fragmentation of the analyte leading to complex and difficult mass spectra to 
interpret.
Mass spectrometry may give the mass of a protein but it does not directly give any 
information about the identity or sequence of a protein. One approach for identifying a 
protein using MS is to use an enzyme to cleave the protein at sequence specific locations. 
The result is a set of peptides unique to the protein created by the chosen enzyme; this is 
called the ‘peptide mass fingerprint’ (PMF). A protein can be identified by comparing 
the experimental PMF with a database of theoretical PMFs of all proteins in the chosen 
database [18]. The ability to identify a protein from its PMF is due to the specific nature 
of the enzymatic digestion of the protein into peptides. The most commonly used 
enzyme, by far, is trypsin. This enzyme cleaves the C-terminal peptide bond of two 
amino acids: arginine and lysine. Other commonly used enzymes include chymotrypsin, 
pepsin, endoprotinase Lys-C, and endoprotinase Asp-N.
In some cases the PMF may not give enough information to identify a protein; 
there may be peaks that do not match the theoretical PMF. This may be because there are
post translational modifications (PTM) on the protein and these are not accounted for, 
unless specified, in a database search. A PTM refers to changes made to the protein after 
being synthesized which changes its properties. PTMs can determine the reactivity and 
localization of a protein as well as how it interacts with other proteins [19]. A PTM 
changes the PMF of a protein by either adding or removing functional groups from the 
protein thereby changing the mass [19, 20]. Some important PTM include: 
phosphorylation [21, 22], glycosylation [23, 24], methylation [25], and ubiquitination 
[26]. Each PTM results in a characteristic change in the mass of the protein. In order to 
characterize unknown proteins or to identify the location of a PTM the peptides from the 
PMF are sequenced by being subjected to another analysis by MS followed by a database 
search. This is called tandem mass spectrometry (MS/MS) and allows each peak in the 
PMF to be sequenced in two steps. The first step involves isolating the peptide peak of 
interest and then fragmenting the selected peptide into smaller ions using collision 
induced dissociation (CID) with an inert gas (argon, nitrogen, xenon). The peptide 
fragments are then directed to a second mass analyzer where they are detected based on 
their mass-to-charge ratio (m/z). The fragmentation pattern can then be used to search for 
the amino acid sequence corresponding to the peptide and ultimately to identify the 
protein of interest.
To ensure high quality MS spectra the protein or peptide sample must be purified 
prior to MS analysis. Purification removes species which would interfere with MS 
detection such as salts, buffers, detergents, and surfactants. Additionally, the proteins of 
interest must be separated from other proteins in the sample to reduce ion suppression. In 
biological samples the concentration of proteins can vary dramatically, from a few copies
to several thousand. During analysis with MS, proteins or peptides present in the highest 
amounts tend to suppress the signals of the less abundant proteins and peptides. It is for 
this reason that separation and/or fractionation steps are employed prior to MS analysis. 
The most commonly used method for separation is two-dimensional gel electrophoresis 
(2D-GE). The term two dimensional refers to the separation of the analytes based on two 
different properties. In the first dimension proteins are separated based on their 
isoelectric point (pi); this is called isoelectric focusing (IEF). The term p/refers to the 
pH at which an analyte has a net neutral charge and is estimated from the pi values of 
individual amino acids. The second dimension separates analytes based on their 
molecular mass using a technique called sodium dodecyl sulfate polyacrylamide gel 
electrophoresis (SDS-PAGE). The main advantage of using 2D-GE is that a large 
number of proteins can be separated and visualized in a single run. However, extracting, 
digesting, and MS analysis of each spot in the gel is extremely time consuming and 
laborious; making high throughput analysis difficult.
An alternative to gel-base separations is high performance liquid chromatography 
(HPLC). There are many different modes of HPLC which allow for multidimensional 
separations of biological samples. The most commonly used modes include reversed 
phase chromatography (RP), affinity chromatography, ion exchange chromatography 
(cation or anion exchange), and size exclusion chromatography (SEC). HPLC is also able 
to facilitate sample preparation techniques such as preconcentrating dilute samples and 
on-column reactions. The sample preparation techniques can be integrated with 
separation methods resulting in reduced sample consumption and sample handling. 
Integrated methods are desirable because they enable automation and allow for high
5
6
throughput analysis. In most cases the HPLC instrument is directly coupled to MS for 
online analysis and increased throughput. There are some problems with HPLC: there 
can be leakages due to the high pressures used, irreversible binding of proteins to the 
column resulting in inefficient protein recoveries, and there is variation in the packing of 
each stationary phase resulting in column-to-column variability.
A separation technique called capillary electrophoresis (CE) offers advantages 
over the conventional techniques of 2D-GE and HPLC. Separation in CE is achieved by 
analyte ions in solution being separated based on their charge-to-size ratios. One major 
advantage CE has over 2D-GE is that much higher voltages may be used during 
separation. This is due to the high surface-area-to-volume ratio which allows for very 
effective dissipation of heat. L •
There have been several modes of CE developed, with the most commonly used 
being capillary zone electrophoresis (CZE) which separates analytes based on their 
charge-to-size ratio. Micellar electrokinetic chromatography (MEKC) is used to separate 
neutral analytes based on their interactions with micelles of surfactant which act as a 
pseudostationary phase. Capillary isoelectric focusing (CIEF) is performed by using 
ampholytes to create a pH gradient and the proteins are separated based on their p/; this 
mode is analogous to IEF performed in gels.
There has been a trend toward miniaturization and development of microfluidic 
(and ultimately lab-on-a-chip) devices. Microfluidic devices are used to manipulate very 
small volumes of fluid by using voltage and pressure to move the fluids through micro 
channels etched onto the surface. A lab-on-a-chip uses microfluidics to perform an entire
7
analysis on a single platform. Capillary electrophoresis has found itself in an 
advantageous position when it comes to developing techniques for microfluidic devices. 
This is because the use of voltage and pressure as well as the small dimensions of the 
capillary makes CE ideal for developing miniaturized techniques for use on these devices. 
It is here that CE has several advantages over the traditional techniques of HPLC and gel 
electrophoresis. While HPLC has been used on microfluidic devices, special setup for the 
use of high pressure is required which can be laborious and time consuming. Gel 
electrophoresis becomes very similar to capillary gel electrophoresis (CGE) when used on 
a microfluidic device due to the increased surface area-to-volume ratio.
One of the main driving forces of developing lab-on-a-chip type devices is the 
desire to integrate experimental steps. Integration of sample preparation and separation
not only reduces sample handling and reagent consumption, it also allows for automation/
which can greatly increase throughput and reproducibility. There has been ongoing 
research into integrating sample preparation with separation steps in CE as well as 
performing reactions inside the capillary. Sample preparation steps performed usually 
involve enrichment of the analyte and in-capillary reactions have generally focused on 
enzymatic digestions and labeling reactions [27-31].
This thesis aims to investigate sample preparation techniques using CE for 
functions beyond separation. Chapter 2 investigates a combination of two previously 
reported techniques which allows for selective sampling of low p/peptides followed by 
enrichment and detection using MS. Chapter 3 studies an in-capillary reaction which is 
commonly used in the study of phosphoproteins. The extent of the reaction is monitored 
using MS.
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1.2 Theory and Instrumentation of Capillary Electrophoresis
Electrophoresis is a separation method based on the differential movement of 
charged analytes in an electric field. The analytes are separated based on their, charge and 
size. Traditional electrophoresis is performed in slab gels such as polyacrylamide or 
agarose and is used to separate biological macromolecules. Using a gel as the medium 
for separation reduces convection as well as thermal diffusion as compared to in solution. 
These slab gels are one of the most commonly used separation methods in proteomics. 
However, the gels suffer from poor dissipation of Joule heat; heat caused by the flow of 
current through the gel. Joule heating causes band broadening which acts to decrease 
resolution. Due to the heat generated, a low electric field must be used (100-300 V) 
which increases run times and lowers efficiencies. '
An alternative to slab gel electrophoresis is to perform the separation in narrow- 
bore capillaries. The large surface area-to-volume ratio results in very efficient dissipation 
of heat and thus high electric fields (up to 30 000 V) may be applied. This results in 
shorter analysis times as well as high separation efficiencies. The capillary eliminates the 
need to use a gel since the heat is so efficiently dissipated and generally only buffers are 
present inside the capillary. The capillaries are normally made of fused silica and have an 
inner diameter (i.d.) in the range of 25-100 pm, an outer diameter (o.d.) of 300-400 pm, 
and are usually 40-100 cm in length. The outer surface of the capillary is coated with 
polyimide to prevent breakage and also gives flexibility making the capillary easier to 
work with.
9
1.2.1 CE Instrumentation and Analysis
One of the advantages of capillary electrophoresis (CE) is the simplicity of the 
instrumentation. Essentially all that is needed is a high voltage power source, a capillary, 
two buffer reservoirs which contain both the capillary and electrodes connected to the 
power supply, and a detector. A schematic of the CE setup is shown in Figure 1.1. The 
most commonly used mode in CE is capillary zone electrophoresis (CZE). This 
separation mode is based on differences in the charge and size ratio of the analytes. In 
order to perform an analysis using CZE, the capillary must first be filled with buffer 
which is done by applying pressure at the inlet buffer reservoir. The sample is then 
injected by replacing the buffer at the inlet with the sample solution. The sample plug is 
usually 1-2 % of the total length of the capillary and is injected hydrodynamically (with 
pressure) or electrokinetically (with voltage application). Once the sample is in the 
capillary, the sample reservoir is replaced with buffer and voltage is applied. The 
analytes become separated based on their charge-to-size ratio and form separate sample 
zones. The analytes are mobilized not only by their electrophoretic mobility, which is 
based on their charge-to-size ratio, but also the electroosmotic flow (EOF, which will be 
discussed in the next section) towards the cathode. The analytes are detected near the 
outlet where a small window was created by burning away the polyimide coating. In 
commercial CE instruments, the temperature is controlled by either thermostated air or a 






1.2.2 Analyte Migration in CZE
1.2.2.1 Electrophoretic Mobility (pe) :
Separations using electrophoresis are achieved by differences in the velocities of 
the analytes in an applied electric field. The electrophoretic velocity (ve) of an ion is 
given by the following equation,
ve — V-e E Equation 1.1 ,
where pe represents the electrophoretic mobility of the analyte and E represents the 
applied electric field, which is a function of the applied voltage and capillary length in 
V/cm. In a buffer of a specific pH the electrophoretic mobility of an analyte can be 
estimated using the Debye-Huckel-Henry theory,
q
~  6 7T r] r  Equation 1.2
where q is the charge of the ion, rj is the viscosity of the buffer, and r is the radius of the 
ion (the ion is assumed to be spherical). From this equation, the electrophoretic mobility 
is proportional to the charge-to-size ratio of the analyte. Generally, small highly charged 
analytes will migrate with a high electrophoretic mobility whereas a large minimally 
charged analyte will have low mobility.
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1.2.2.2 Electroosmotic Mobility (peof)
The electroosmotic flow (EOF) is the bulk flow of liquid in the capillary and 
results from the charged inner surface of the capillary. The EOF is responsible for how 
long an analyte remains in the capillary and the EOF is additive to the electrophoretic 
mobility of the analyte. In fused silica capillaries the EOF is controlled by the silanol 
groups (SiOH) which can also exist in their anionic form (SiO'). Cations from the buffer 
solution build up near the anionic surface, in order to maintain a charge balance, forming 
a double layer (Figure 1.2) and a potential difference is created very close to the capillary 
wall. This potential difference is known as the zeta potential. When voltage is applied 
the cations forming the diffuse layer are attracted to the cathode. Since the cations are 
solvated their movement has the effect of dragging the bulk solution in the capillary 
















Figure 1.2: Illustration of the electrostatic double layer formed electrophoresis in a 
fused silica capillary
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The velocity of the EOF (veof) can be expressed by the electroosmotic mobility (peof)>
and
Veof —  eof E Equation 1.3
Mfof — £ iT1
Equation 1.4
where s is the dielectric constant and £ is the zeta potential. The zeta potential is largely 
dependent on the surface charge of the inner capillary wall. Since the charge on the silica 
is pH dependent, the magnitude of the EOF will vary with the pH. At high pH the silanol 
groups are mainly deprotonated yielding a higher EOF than at low pH where the silanols 
are protonated. The EOF is also affected by the concentration or ionic strength of the 
buffer. A high ionic strength buffer reduces the zeta by compressing the diffuse layer and 
thus reducing the EOF. A unique feature of the EOF is its flat flow profile as opposed to 
a laminar flow which is generated in pressure driven systems (Figure 1.3). The flat 
profile of the EOF is generated because the driving force (cations) of the flow is 
distributed uniformly along the capillary walls resulting in less sample dispersion than 
with laminar flow. The magnitude of the EOF is essentially constant across the capillary 
because the thickness of the diffuse and Stem layers are negligible compared to the 




Figure 1.3: Flow profiles of A) the electoosmotic flow during electrophoresis 
and B) laminar flow during liquid chromatography
1.2.3 Mobility Measurement
The mobility of an analyte in the presence of EOF is called the apparent mobility 
(pa) and is based on the electrophoretic mobility (pe) as well as the electroosmotic 
mobility (peof)- The apparent mobility can be expressed as the sum of the electrophoretic 
and electroosmotic mobilities,
The apparent mobility is measured experimentally from the migration time of the analyte 
in a CZE experiment; it is calculated as follows,
V - a — l*e + H-EOF Equation 1.5
Equation 1.6
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where Ld is the distance from the inlet to the detector, t is the migration time of the 
analyte from the inlet to the detector, E is the applied electric field which can be 
expressed as the ratio of the applied voltage (V) and the total length of the capillary (Lt). 
The units of mobility are usually cm / Vs.
The mobility of the EOF can be determined by measuring the apparent mobility of 
a neutral molecule (a neutral marker) whose net charge is zero. This is possible because 
the neutral marker, having no net charge, is mobilized only by the EOF.
1.2.4 Protein Adsorption
One of the main issues with using fused silica is the adsorption of proteins and 
peptides onto the charged inner wall. Proteins and peptides have multiple charged sites 
and they interact with the silica surface by electrostatic and/or hydrophobic interactions. 
Adsorption alters the EOF leading to irreproducible migration times and separations, 
increased band broadening, decreased efficiency, and reduced sensitivity [32-34]. 
Depending on the pH of the sample, the EOF could be quite fast and sweep the analytes 
past the detector before they are sufficiently separated. Thus, optimization of the EOF is 
required to maximize the efficiency and resolution of separations. It is the charge on the 
inner silica surface which is responsible for both adsorption of analytes and the EOF. 
There are two ways to modify the EOF and control protein adsorption: either control the
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pH or ionic strength of the running buffer [35-37] or modify the physical properties of the 
silica surface [38, 39].
1.2.4.1 Buffer Selection for EOF Modification and Reduction of Analyte Adsorption
One of the simplest ways to minimize analyte adsorption is to control the pH of 
the buffer. The use of a low pH buffer results in protonation of the silanol groups of the 
silica surface which reduces the surface charge as well as electrostatic interactions; there 
is also a reduction in the magnitude of the EOF. Another approach would be to give the 
analytes a negative charge reducing electrostatic attraction. This can be done by using a 
buffer with pH above the p/ of the analyte [40]. However, in general as the pH increases 
so does the magnitude of the EOF. One of the main drawbacks of these strategies is that 
they are limited by the workable pH range as well as the tendency of the solubility and 
stability of proteins and peptides to be compromised at pH extremes.
Another method to reduce analyte adsorption is to increase the ionic strength 
(concentration) of the buffer. The increased ion content of the buffer also decreases the 
zeta potential leading to a decrease in the magnitude of the EOF. Higher ionic strength 
buffers increase the amount of Joule heating due to an increase in the current therefore a 
lower field strength may need to be used. In addition, when coupling CE to mass 
spectrometry (MS) a higher ionic strength buffer can have negative effects on the 
sensitivity and increase ionization suppression.
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1.2.4.2 Coating the Capillary to Modify EOF and Reduce Analyte Adsorption
One of the most common methods to suppress the EOF and reduce analyte 
adsorption is to cover, or coat, the inner capillary wall with a chemical. There are two 
different methods to achieve this: by using either dynamic coatings or covalent coatings.
1.2.4.2.1 Covalent Coatings
These types of coatings are usually polymers which are chemically bonded to the 
silica surface. Some of these coatings include polyamines [41], poly(ethyleneimine) [42], 
poly(acrylamide) [43,44], cellulose derivatives [45], poly(vinyl alcohol) [46], etc. 
Although these types of coatings have demonstrated high stability and reproducible 
migration times their preparation is often time consuming and tedious. Sometimes 
capillary-to-capillary reproduction of the coating is difficult. There are pre-coated 
capillaries of this type commercially available, but they are more expensive than bare 
capillaries which can greatly increase operation costs. Since these coatings are 
permanently attached to the silica surface they are ideal for use with MS analysis.
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1.2.4.2.2 Dynamic Coatings
Dynamic coatings require the coating chemical to be present in the buffer during a 
CE experiment. The coating chemicals absorb onto the silica surface due to electrostatic 
and/or hydrophobic interactions. The coating competes with the analytes for binding sites 
on the silica surface and once bound acts as a shield, reducing analyte adsorption. The 
chemicals used for dynamic coatings include cationic surfactants such as polyamines [47] 
and cetytrimethylammonium bromide (CTAB) [48], zwitterionic surfactants [49], 
fluorosurfactants [50-52], and neutral molecules such as poly(vinyl alcohol) [46] and 
polyethylene oxide) [53].
Dynamic coatings are easy to use since the chemical is added directly to the run 
buffer. The coatings are generally quite stable since the coating is continually being 
refreshed which yields highly reproducible and efficient separations. However, dynamic 
coatings are incompatible with MS due to the presence of the coating in the buffer. There
' : ' .................................................  ’ 1 ' ' i
are issues with intense background peaks and ionization suppression.
In an attempt to make dynamic coatings more compatible with MS semi­
permanent coatings have been developed. A semi-permanent coating differs from 
dynamic coatings in that they are not required in the running buffer and thus are generally 
compatible with MS. There are many different types of molecules used as semi­
permanent coatings [54-56]. One class which has gained interest recently is surfactants 
due to their low cost and ease of use. These molecules are amphiphilic which means they 
contain a hydrophilic head group and one or more hydrophobic tails. When the 
concentration of the surfactant is above the critical micelle concentration (CMC) the
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molecules aggregate to form micelles with the hydrophilic head pointing outwards and 
the hydrophobic tails pointing inward (Figure 1.4 A). Double-chained surfactants have 
been found to form a very stable bilayer on the silica surface (Figure 1.4 B) [57].
Figure 1.4: Structures of aggregated A) single chained surfactants and B) double 
chained surfactants.
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Melanson et al. reported the use of a double chained cationic surfactant called 
didodecyldimethylammonium bromide (DDAB) [58]. The DDAB molecules were shown 
to form a bilayer on the silica surface (Figure 1.4 B). The DDAB coating was found to 
be very stable, maintaining a stable EOF for 75 min. The separation of four cationic 
proteins was highly efficient (up to 750 000 plates/m) and the authors reported 
quantitative recoveries of the proteins [58]. Even though this coating was efficient at 
separating cationic proteins, adsorption of anionic proteins was inevitable due to the 




Figure 1.5: Chemical structures of some double chained surfactants. A) DDAB, Cis; 
B) DLPC, Cï2; C) DMPC, CM; D) DMP A, C,4.
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Another type of double chained surfactant which forms semi-permanent coatings 
and has recently been successfully employed in highly efficient CE separations are 
zwitterionic phosphatidylcholines which are a type of phospholipid. Phospholipids 
possess a polar hydrophilic head group (where the phosphate and other functional groups 
reside) and a double chained hydrophobic tail (Figure 1.5 B, C). These surfactants form 
what is called a supported phospholipid bilayer (SPB) and are often used in membrane 
studies [59-64]. The first reported use of this type of molecule as a coating in CE was 
with l,2-dilauroyl-5n-phosphatidylcholine (DLPC, 2C12) (Figure 1.5 B) by Cunliffe et al. 
[65]. The DLPC coating was used to separate a mixture of both cationic and anionic 
proteins with very high efficiencies (up to 1.4 million plates / m). The coating was also 
found to suppress the EOF and prevent adsorption of both cationic and anionic proteins 
over a large pH range (pH 3-10). Another zwitterionic phospholipid similar to DLPC:
1,2-dimyristoyksYi-glycero-3-phosphocholine (DMPC, 2Cm) (Figure 1.5 C) has been 
used to suppress the EOF to facilitate selective sampling of [66] and preconcentration [1] 
of phosphopeptides. In Chapter 2, a solution of DMPC and an anionic phospholipid 1,2- 
dimyristoyl-jn-glycero-3-phosphate (DMPA) (Figure 1.5 D) was used to suppress the 
EOF and minimize adsorption of peptides onto the silica surface.
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1.3 Mass Spectrometry in Protein Analysis
1.3.1 Instrumentation of Mass Spectrometry
The basic components of a mass spectrometer are an ion source, a mass analyzer 
and a detector. The ion source converts the analyte molecules into ions. Ionization of the 
analyte typically involves the addition or removal of an electron or proton(s). The energy 
transferred during ionization may fragment the analyte into characteristic fragments. 
There are several methods to ionize the sample, however thè most commonly used 
ionization methods in proteomics are matrix assisted laser desorption/ionization 
(MALDI) and electrospray ionization (ESI). The reason these two ionization methods are 
preferred in proteomic analyses is due to their 'soft ionization' mechanisms. In contrast to 
other ionization mechanisms MALDI and ESI are able to generate intact gas-phase ions 
from large biomolecules with little fragmentation. Once the ions are generated they move 
into the mass analyzer where the ions are separated based on their mass-to-charge ratio 
(m/z). There are many types of mass analyzers and the most commonly used include 
time-of-flight (TOF), quadrupole (Q), Fourier-transform ion cyclotron resonance (FT- 
ICR), ion trap, and orbitrap. Mass analyzers can also be coupled together to perform 
tandem mass spectrometry (MS/MS). Some common examples of MS/MS setups include 
triple quadrupole (QqQ), quadrupole-time-of-flight (QTOF), and TOF-TOF.
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1.3.2 Soft Ionization Mechanisms: Electrospray Ionization and Matrix Assisted Laser 
Desorption/Ionization
1.3.2.1 Electrospray Ionization
Electrospray ionization (ESI) transfers analytes from solution into gas phase ions. 
The development of ESI coupled to a mass analyzer (ESI-MS) was credited to John Fenn 
in 1984, for which he later received the 2002 Nobel for [15]. As the name implies, this 
ionization method produces a fine spray of highly charged droplets containing the analyte 
ions. The sample solution must be continuously flowing (pL/min to nL/min) through a 
capillary tip which has a potential applied to it (1 -  5 kV) and is usually made from 
stainless steel (Figure 1.6). There are three major steps involved in the formation of gas 
pháse ions: 1) formation of a fine mist of charged droplets from the capillary tip; 2) 
shrinkage of the droplets by evaporation of the solvent (usually by a curtain of inert gas) 
which leads to very small highly charged droplets; and 3) the formation of gas phase ions
from the small highly charged droplets (Figure 1.6). All three steps of ion formation
\
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Atmospheric Pressure Vacuum
Figure 1.6: Schematic of a CE-ESI MS interface. The sheath liquid aids in the 
ionization of the CE eluent; the curtain gas is used to facilitate evaporation of the 
solvent and promote the formation of gas phase ions; once formed, the gas phase ions 
are directed to the mass analyzer.
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One of the main advantages of ESI is that it can be directly coupled to LC and CE 
since the ionization process occurs at atmospheric pressure. When coupled to CE a 
sheath flow is often used (Figure 1.6). The sheath liquid acts as the outlet buffer 
reservoir for the CE experiment, ensuring electrical continuity. The sheath liquid mixes 
with the CE eluent at the ESI tip and carries the eluent into the mass spectrometer. With 
this setup, the CE eluent is diluted by the sheath liquid reducing sensitivity.
This ionization process generates molecular ions with multiple charges which 
enables an ordinary mass analyzer (not designed for high mass analytes) to effectively 
analyze very large analytes (> 10 kDa). However, multiply charged ions make the mass 
spectrum difficult to analyze and interpret, especially when complex samples are used. In 
addition to complex mass spectra, this ionization method is quite sensitive to the presence 
of salts and detergents which may be present in the sample. These contaminants form 
adducts with the analytes and can also compete for ionization. So it is important the 
samples are clean before ionization.
1.3.2.2 Matrix Assisted Laser Desorption/Ionization
Matrix assisted laser desorption/ionization (MALDI) was first described in 1987 
by Karas and Hillenkamp; in 1988 they analyzed the first proteins [67, 68]. This 
ionization method involves mixing the protein or peptide solution with a chemical called 
the matrix followed by deposition onto the MALDI target. The matrix is usually a small 
organic molecule containing an aromatic region which strongly absorbs the laser light. 
The solvent is allowed to dry resulting in co-crystallization of the matrix and sample. The
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target is then introduced into the vacuum of the mass spectrometer. A short laser pulse is 
fired at the co-crystallized sample and matrix resulting in localized sublimation and 
ionization of the matrix. Some energy absorbed by the matrix is transferred to the sample 
molecules resulting in their desorption and ionization.
One of the main advantages of MALDI over ESI is that MALDI is much more 
tolerant of high salt, buffer, and/or contaminant concentrations. Furthermore, MALDI 
generally generates singly or doubly charged ions resulting in spectra that are easier to 
interpret.
1.3.2.2.1 Sample Preparation and Matrix Selection for MALDI MS
There are several methods in which to mix the sample and the matrix. The ‘dried 
droplet' method is considered by many to be the standard in MALDI sample preparation 
[69, 68]. The sample and matrix are mixed together and then spotted onto the MALDI 
target. The droplet is usually in the range of 0.5 -  1 pL in volume. Another deposition 
technique called the 'three layer method' is often used when coupling CE to MALDI MS 
[70]. The method involves spotting a thin layer of matrix crystals on the target surface. 
The second layer is matrix which is more concentrated than the first layer resulting in a 
thicker matrix layer. The third layer is the sample. Other commonly used sample 
deposition methods for MALDI MS include the sandwich method [69], crushed crystal, 
and two layer method [71].
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There are several matrices that can be used for MALDI, with the most commonly 
used types shown in Figure 1.7. The matrix chosen is dependent on the type of sample 
being analyzed. For example, CHCA is most often used for general proteomics analysis 
while DHB is often used when studying peptides and proteins with low p/ (such as 
phosphoproteins and phosphopeptides). One of the main problems associated with many 
MALDI matrices is the formation of 'sweet spots’. This is where the crystallization of the 
sample is not uniform throughout the matrix crystals resulting in areas with high amounts 




Figure 1.7: Chemical structures of several common molecules used as MALDI 
matrices: A) 2,5-dihydroxybenzoic acid (DHB) B) a-cyano-4-hydroxycinnamic 
acid (CHCA) C) cinnamic acid D) sinapinic acid.
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1.3.3 TOF Mass Analyzer
The concept of the time of flight (TOF) mass analyzer is that ions are accelerated 
through an electric field and then allowed to 'drift' through a tube at the end of which is a 
detector. In practice this is achieved by accelerating all ions to a constant kinetic energy 
and then measuring their flight time. With a fixed kinetic energy small ions will travel at 
a higher speed than large ions as shown by:





f _  l _  l l I™ — a I™ Equation 1.9
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Where z is the charge of the ion, m is the mass of the ion, v is the velocity of the ions, e is 
the electron volt (1.6xl0'19 J), V is the voltage of the pulse applied to the ion source, t is 
the time it takes the ion to reach the detector, and 1 is the length of the TOF analyzer.
From these equations, ions with different m/z have different velocities (Equation 
1.9) and therefore reach the detector at differing times (Equation 1.10).
One of the most important aspects of this mass analyzer is that the ions need to be 
generated at a known start time and position. It is for this reason that MALDI is most
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often used with this mass analyzer. The advantages of the TOF analyzer include a 
theoretically unlimited mass range, very high sensitivity due to high ion transmission, and 
the instrumentation is fairly simple and straightforward. However, the resolution is 
limited due to variation in ion energy.
The simplest configuration of MALDI TOF is linear mode. Once the ions are 
formed they are accelerated into the drift region of the mass analyzer and then strike a 
detector at the opposite end, as shown in Figure 1.8 A.
In order to address the issue of low resolution an ion mirror or reflectron can be 
added (TOF-R). The reflectron uses an electrostatic field to reflect ions at an angle 
towards a different detector than used in linear mode (Figure 1.8 B). Essentially, the 
reflectron causes ions with the same m/z but higher kinetic energy to penetrate the ion 
mirrors more deeply than those with a lower kinetic energy. This has the effect of 
delaying the arrival time of the higher energy ions at the detector. The addition of the 
reflectron results in improved resolution compared to linear mode. However, the 
reflectron is generally only useful for peptides and small proteins (> 10,000 Da) due to 
decreased sensitivity and metastable decay of larger ions. Metastable decay is due to the 
unstable high mass ions which can decay during their flight in the TOF analyzer [72].
The result of metastable decay is peak broadening. In this thesis, a MALDI TOF 














©  Same ion with high velocity 
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Figure 1.8: Schematic of a MALDI TOF interface. A) linear detection 
mode: a laser pulse desorbs and ionizes both sample and matrix molecules; 
the ions drift through the TOF analyzer and are detected and B) reflectron 
detection mode: same as linear mode except ion mirrors at the end of the TOF 
tube redirect and focus same m/z ions with different velocities to detector.
1.4 Coupling Capillary Electrophoresis to MALDI MS 
1.4.1 Online CE MALDI MS
It is possible to couple MALDI MS in an online fashion to CE with some clever 
modifications. Online CE MALDI MS is desirable due to reduced sample handling thus 
reducing sample loss. Another reason is that speed and throughput would be increased 
with an online approach. One reported online CE MALDI MS method involves 
depositing a flow (100-400 nL/min) of sample onto a rotating quartz wheel inside the 
vacuum region of the mass spectrometer [73, 74]. Once the solvent has evaporated a 
trace or streak of sample is left on the wheel which is then rotated to be irradiated with the 
laser. The capillary eluent is mixed with the MALDI matrix using a liquid junction 
located after the window for UV detection. The authors reported a high performance 
separation of a mixture of 12 peptides as well as a detection limit in the attomole range 
[74].
Another online CE MALDI MS method called rotating ball interface (ROBIN) 
has been reported [75, 76]. In this technique a stainless steel rotating ball is used to 
introduce the eluent from the separation to the laser for analysis. The ball acts as the 
cathode during the CE separation. There is another capillary filled with the running 
buffer to maintain a steady current during the separation, the buffer is supplied by a 
syringe pump. The matrix is deposited onto the ball by a third capillary. Unlike the 
previous example, the deposition of the sample is performed at atmospheric pressure and 
is then introduced to the vacuum of the mass spectrometer by rotation of the ball. Once
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the sample has been analyzed there is a felt pad soaked in solvent to remove the leftover 
sample and matrix. The authors report detection limits in the high femtomole range, they 
also demonstrated the separation of a mixture of peptides [75].
1.4.2 Offline CE MALDI-MS
In continuous offline CE MALDI MS the eluent is deposited onto a MALDI target 
while maintaining electrical contact to allow the separation to proceed. In a method 
called vacuum deposition, the end of the separation capillary is connected to a tapered 
capillary which is in constant contact with the MALDI target allowing for continuous 
sample deposition [77]. The tapered capillary was fed into a chamber under vacuum and 
controlled with X-Y translational stages. The eluent was deposited in a 100 pm wide 
trace in a zig-zag pattern on the target. After deposition of the sample, the target was 
placed in a MALDI TOF mass spectrometer for analysis. The authors reported highly 
reproducible signals from MALDI MS analysis, on par with what is obtained from theV
'dry droplet’ method [77]. The benefits of continuous offline CE and MALDI steps 
include no constraints on separation time or MS acquisition speed. Additionally, the 
decoupled setup allows sufficient time after the initial MS analysis for selection of 
specific m/z ions for MS/MS analysis. Unfortunately these modifications are not 
commercially available and require significant time for setting up.
Another offline method for CE MALDI MS is to decouple the separation and 
spotting steps and use pressure to spot the contents of the capillary onto the target. In this 
method the voltage is suspended when the analyte reaches the end of the capillary and
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low pressure applied from the inlet is used to deposit the sample on the target. Since it 
must be known when the analyte reaches the end of the capillary an online detector must 
be used with this method. Due to the simplicity, this method of CE MALDI MS was used 
for all mass spectrometric analyses in this thesis. The three layer matrix spotting method 
was also used.
1.5 Overview of This Thesis
The main goal of this thesis is to investigate sub-microliter volume sample 
preparation techniques with potential applications to phosphorylated proteins/peptides. 
There were two different techniques investigated. One involved integration of two 
methods previously developed by our research group: selective sampling of peptides 
based on their isoelectric point (pi) followed by enrichment using a pH junction method 
with discontinuous buffers (Chapter 2). In addition to enrichment it was anticipated 
there would be some separation of the enriched peptides based on their pI. The second 
technique investigated miniaturization of a methyl esterification reaction which is 
commonly used prior to separation and/or fractionation of phosphopeptides (Chapter 3). 
The esterification occurs at all carboxyl functional groups on the peptides present in the 
sample solution. This has been shown to reduce non-specific binding of acidic peptides 
in isolation techniques which utilize the negative charge of the phosphate to remove the 
phosphopeptides from the rest of the sample. Successful miniaturization of this reaction 
inside a capillary will allow its integration with devices for future development.
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Chapter 2: An Integrated Procedure of Selective Sample Injection and 




Phosphorylation is a reversible post-translational modification (PTM) involved in 
many important cellular processes such as signaling, translation, regulation, and 
metabolism [2]. At any one time at least 30% of proteins are thought to be 
phosphorylated. With so many proteins affected by this PTM it should come as no 
surprise that diseases such as cancer and diabetes have been linked to irregularities in this 
PTM [3,4]. There are four types of phospho-amino acid residues: O-phosphates, N- 
phosphates, acylphosphates, and 5-phosphates [5], The most common type are the O- 
phosphates (Figure 2.1) and it is for these residues that most phosphoproteomic methods 
are developed [6]. The O-phosphates include phosphorylation of the amino acids serine, 
threonine, and tyrosine.
Phosphotyrosine
Figure 2.1: Chemical structures of three O-phosphates: phosphoserine, 
phosphothreonine, and phosphotyrosine.
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In the study of phosphoproteins mass spectrometry (MS) has emerged as the ideal 
choice for identifying phosphorylation sites. However phosphopeptides suffer from low 
sensitivity in MS. The negatively charged phosphate group affects the ionization and 
therefore detection of the peptide in positive ion mode; which is more sensitive than 
negative ion mode. This becomes more problematic when studying peptides with 
multiple phosphorylation sites. In addition, other more basic (higher p7), peptides act to 
further reduce the MS signal by suppressing the ionization of the phosphorylated 
peptides.
There has been considerable effort spent on enhancing the signals of 
phosphopeptides in MS. It has been reported that the addition of ammonium salts, such 
as ammonium citrate, to the matrix when using MALDI are effective in increasing the 
signal strength of phosphopeptides [7, 8]. It is thought the ammonium ions work as 
proton donors and reduce the anionic character of the phosphopeptides resulting in 
increased ionization efficiency. Along the same idea of matrix additives, it has been 
shown that the addition phosphoric acid to the MALDI matrix also increases the signal 
strength of phosphopeptides [9,10]. The phosphoric acid was reported to improve the 
incorporation of the phosphopeptides into the matrix lattice during spotting. There have 
also been several reports of chemical modifications to the phosphate group [11-13]. The 
phosphate group may be removed to form a lysine analog which increases the ionization 
efficiency [14]. One technique which may be the simplest is to use negative ion mode in 
MS analysis [15-18].
In addition to the previously mentioned techniques to increase the signals of 
phosphopeptides during MS, there has been considerable effort in developing methods to 
separate and isolate phosphopeptides prior to MS. The most commonly used methods are
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mainly sorption based. Immobilized metal affinity chromatography (IMAC) (using Fe , 
Ga+3, Ni+2, and Zr+4) is one of the more commonly used methods [10,19-29]; others 
include metal oxide affinity chromatography (MOAC) (using TiC>2, ZrC>2, AI2O3, and 
Nb205) [30-37], and ion exchange chromatography [38-41]. In these methods, the 
phosphate group exhibits some affinity for the stationary phase and becomes temporarily 
bound to it. The other peptides do not interact with the stationary phase and are flushed 
from the column. The phosphorylated peptides are then eluted and collected and may be 
further separated and/or purified before MS analysis. Even though the non- 
phosphorylated peptides are not supposed to bind to the stationary phase, there can be 
non-specific binding of acidic peptides. Non-specific binding generally occurs with 
peptides that have carboxylic acid groups on their amino acid side chains. The carboxyl 
groups can interact with the stationary phase in a similar way to the phosphate group on 
phosphorylated peptides. In order to reduce this non-specific binding, the sample is often 
subjected to an esterification reaction which converts all carboxylic acid groups into 
methyl esters [42]. While these methods have been successful in improving MS detection 
of phosphopeptides there is the risk of irreversible binding resulting in sample loss. This 
can be problematic when analyzing low concentration samples. Also, non-specific 
binding of acidic amino acid residues to the stationary phase can result in their presence 
in MS. Development of non-sorption based purification and enrichment methods would 
be ideal. Yeung’s group has been successful in developing a method to selectively 
sample and enrich phosphorylated peptides using capillary electrophoresis (CE) [43,44, 
1]..
In the technique developed in Yeung’s group, phosphorylated peptides are • 
selectively sampled from the bulk sample by utilizing the fact that phosphorylated
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peptides tend to have lower iso-electric points than non-phosphorylated peptides [43]. 
Thus at low pH, the phosphopeptides would have a greater probability of bearing a net 
negative charge while non-phosphorylated peptides (with a higher pi) would be more 
likely to be either neutral or possess a net positive charge. By utilizing this information, 
phosphopeptides can be selectively migrated into a capillary while the neutral and 
positive peptides remain in the sample vial. This sampling method has been used to 
isolate phosphopeptides from non-phosphorylated peptides even with the concentration of 
non-phosphopeptides at 1 million times greater than the desired analyte [43,44]. In 
addition, an attomole detection limit was achieved when selective sampling was 
combined with matrix assisted laser desorption/ionization (MALDI) with nanoliter 
volume sample spots [43,44].
The selective sampling method was then integrated with an enrichment step [1].
In this method, enrichment was achieved by using a technique called stacking. Sample 
enrichment by stacking occurs when there is a sudden reduction in the mobility of the 
analyte. One method of reducing the mobility of the analyte is to change the conductivity 
of the running buffer; called field amplified stacking (FASS). A change in conductivity 
can be achieved by introducing a zone with low conductivity where injection takes place; 
a plug of water is often used. The analyte ions will have a higher mobility in the plug of 
water and therefore migrate faster in this zone. When the ions reach the boundary 
between the water plug and the running buffer they will slow down and stack as they 
cross the boundary. In the work reported by Zhang et al. a plug of water was injected to 
create the zone of low conductivity (Figure 2.2 A) [1]. The analytes were then 
selectively injected based on their pI, stacked at the water-buffer boundary (Figure 2.2 
B), and then electrophoresis based on the size-to-charge ratio was performed (Figure 2.2
C). The analytes were then spotted onto a MALDI target in nano-liter volume spots 
(Figure 2.2 D). The integrated procedure yielded an enrichment factor of 600 [1].
A: Water plug introduced to create a zone of low conductivity
H20 Buffer
B: Selective injection of anions and mobility reduction at the water-buffer 
boundary resulting in stacking
C: Electrophoretic separation of anions based on their size-to-charge ratio
D: Sample spotting onto MALDI target
Figure 2.2: The integrated procedure of selective injection, sample stacking, and 
electrophoresis of phosphopeptides reported by Zhang et al in ref [ 1 ].
The work presented herein is similar to that which was presented by Zhang et al in 
that selective injection was used to introduce the desired analytes into the capillary. The 
difference between the two methods lies in the technique used to enrich the peptides. 
While both methods utilize stacking techniques the previous work uses field strength to 
alter the mobility of the analytes and the method presented here uses a pH boundary to 
change the ionization state of the analytes which alters their mobility. In the work 
presented here the analytes were selectively injected based on their p/ (Figure 2.3 A) and 
then acidic (pH 3) and basic (pH 9.75) buffers were placed at the inlet and outlet, 
respectively, to create two pH junctions at each end of the capillary (Figure 2.3 B). 
Enrichment occurred due to stacking at the pH junctions. At the pH 3 and pH 5 junction, 
anions with a pi between 3 and 5 would be trapped and enriched. If they migrated into 
the pH 3 buffer they would become positively charged (since the pH was less than the pi) 
and migrate back to the pH 5 zone (Figure 2.3 C). At the other junction (pH 5 and pH 
9.75) the opposite effect was occurring: any analyte migrating into the pH 9.75 buffer 
become more negatively charged and migrate back into the pH 5 zone (Figure 2.3 C).
The migration of the pH junction moved the enriched analyte zone toward the detector 
which was then spotted on a MALDI target for MS analysis (Figure 2.3 D).
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pH 3 Buffer ,̂75
Buffer Buffer
C: Enrichment of analytes
pH 5
D: Electrophoresis of enriched analytes toward detector
pH 3 pH 9.75
Buffer Buffer
Figure 2.3: The integrated procedure of selective injection, sample enrichment, and 




2.2.1 Apparatus .. .
All selective injection and enrichment experiments were performed using an 
Agilent 3D-CE Capillary Electrophoresis Instrument (Palo Alto, CA, USA). Direct UV 
absorbance detection was performed at 254 nm for mesityl oxide (EOF marker) and 200 
nm for peptides. Data acquisition was enabled by the use of the ChemStation software 
provided by Agilent. Fused silica capillaries were purchased from Polymicro 
Technologies (Phoenix, AZ, USA). The dimensions of the capillaries were 50 pm I.D 
(inner diameter), 360 pm O.D (outer diameter), 48.5 cm in total length, and 40 cm to the 
detector window. The capillaries were thermostated at 25 °C. Mass spectral data was 
obtained using a Bruker Reflex IV MALDI time-of-flight (TOF) mass spectrometer 
(Bremen/Leipzig, Germany). The instrument was equipped with a 3 ns 337 nm nitrogen 
laser. Reflectron and positive ion mode were used. Mass spectra were recorded as sums 
of 50 individual laser shots using video monitoring. Igor Pro (WaveMetrics, Lake 
Oswego, OR, USA) was used for data processing and presentation of mass spectral and 
CE data.
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2.2.2 Chemicals and Reagents
Zwitterionic surfactants 1,2-dimyristoyl-s«-glycero-3 -phosphocholine (DMPC, 
C14) and 1,2-dimyristoyl-stt-glycero-3 -phosphate (DMPA, C13) were obtained from 
Avanti Polar Lipids, Inc. (Alabaster, AL, USA). The phospholipid solutions were 
prepared as 0.1 mM solutions in 20 mM Tris-HCl at pH 7.2 with 20 mM calcium chloride 
as previously reported [45]. Calcium chloride is used to promote the formation of the 
phospholipid bilayer on the silica surface. Briefly, the 0.1 mM solutions were sonicated 
for 10 min and then allowed to cool to room temperature with stirring. This cycle was 
repeated until a clear, colourless solution was observed. The DMPC and DMPA were 
then mixed at the appropriate ratio and subjected to the sonicate/stir procedure until a 
clear, colourless solution was observed. All solutions were prepared using 18.2MG 
deionized water from a Millipore Water Purification System (Bedford, MA, USA).
ACS grade phosphoric acid, ammonium hydroxide, sodium hydroxide, formic 
acid, and hydrochloric acid were purchased from EM Science (Gibbstown, NJ, USA). 
OmniTrace grade glacial acetic acid was also purchased from EM Science. Mesityl 
oxide, ammonium citrate, tris(hydroxymethyl)aminomethane (tris), ammonium 
bicarbonate, and 2,5-dihydroxy benzoic acid (DHB) were purchased from Sigma Aldrich 
(Markham, ON, Canada). Calcium chloride and HPLC grade methanol were purchased 
from Caledon (Georgetown, ON, Canada). ACS grade acetone was obtained from 
Fischer Scientific Ltd. (Nepean, ON, Canada). Ethanol (95%) was purchased from 
Commercial Alcohols, Inc. (Brampton, ON, Canada).
Adrenocorticotropic hormone fragment 18-39 (ACTH, MW 2465.7, p/4.25), 
angiotensin I (AI, MW 1296.5, pi 6.92), and bradykinin (BK, MW 1060.2, p / 12.00) were
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purchased from Sigma Aldrich. The iso-electric points were calculated using an online pi 
calculator provided by ExPASy [46].
2.2.3 EOF Suppression and Measurement
Controlling the EOF to prevent non-selective injection of the sample solution is of 
utmost importance in ensuring the success of the selective injection. With the 
experimental set-up used an EOF in the forward direction (cathodic) is required. A 
reversed EOF (anodic) would not allow for selective sampling injection since the 
direction would be from the vial into to the capillary and all peptides in the sample would 
be injected. In addition to the direction, the magnitude of the EOF must be controlled.
An EOF which is too fast would not allow the peptides to migrate into the capillary.
Thus, the direction and magnitude of the EOF must be controlled to allow the maximum 
amount of peptides to be selectively injected. The magnitude of the EOF can be 
suppressed by using a coating to cover the silanol groups. Since detection will be done 
with MS, a zwitterionic phospholipid semi-permanent coating called DMPC was chosen. 
The direction of the EOF at the selective injection pH 5 was reversed. To change the 
direction of the EOF to forward a negative phospholipid, DMPA was added to the coating 
solution. The coating used was a mixture of DMPC and DMPA which has previously 
been found to be effective in ensuring a forward EOF at acidic pH [47,43]. At pH 5 a 
mixture of DMPC and DMPA (90:10 mole ratio) was used to generate a suppressed 
forward EOF.
Each new capillary was pre-conditioned using high pressure (1 bar) in the 
following sequence: 0.1 M HC1 for 10 min, water for 10 min, 0.1 M NaOH for 10 min,
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water for 10 min, and then the mixture of DMPC and DMPA for 20 min. Prior to each 
run, the coating was reapplied using high pressure for 10 min followed by a 3 min rinse 
with the selective injection buffer (50 mM acetic acid pH 5, adjusted with ammonium 
hydroxide). New capillaries and coating solutions were prepared every 5 days to ensure a 
reproducible EOF.
The EOF was measured using Williams and Vigh’s three-injection method [48]. 
Briefly, two mesityl oxide peaks were injected at a known distance apart. An electric 
field was then applied for a set time enabling the EOF and mobilizing the two mesityl 
oxide peaks. After voltage application a third mesityl oxide peak was injected followed 
by low pressure to push all three peaks to the detector. The EOF can be calculated using 
the following formula:
_  (ti + t3'2t2)V Ld
t oltLt t3 Equation 2.1
The migration times of the mesityl oxide peaks are given by tj, k, and t$, in their elution
order (in s). V is the electric field applied to the capillary (in volts); Lt is the total
\
capillary length while Ld is the length to the detector (both in cm). Finally, tvon is the 
length of time voltage was applied for (in s). EOF measurements were performed in 
replicates of three at each pH. Mesityl oxide (20 mM) was used as an EOF marker.
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2.2.4 Selective Injection with Optical Detection
During selective injection with optical detection, the analyte solution (200 pL in 
buffer) was placed at the detector end of the capillary (8.5 cm to detector) with a buffer 
vial at the other end of the capillary (40 cm to detector). Injection of ACTH was achieved 
by applying +10 kV for 2 min and to inject AI and BK -10 kV for 2 min was used. After 
selective injection the peptides were mobilized to the detector using vacuum (-20 mbar). 
In addition to selective injection, each peptide was hydrodynamically injected (-20 bar for 
1 min) and then mobilized to the detector using vacuum (-20 mbar). The concentration of 
each peptide was 0.1, 0.15, and 0.2 mg/mL for ACTH, AI and BK, respectively.
2.2.5 Evaluation of Peptide Enrichment Using UV Detection
To analyze the enrichment step, the capillary was filled with basic buffer (10 mM 
ammonium adjusted to pH 9.75 with acetic acid), then 0.05 mg/mL ACTH in pH 5 buffer 
(5-50 mM acetic acid adjusted with ammonium hydroxide) was hydrodynamically 
injected to fill about 1/3 of the capillary volume, and finally acidic buffer (10 mM 
formate adjusted to pH 3 with ammonium hydroxide) was hydrodynamically injected to 
fill about 1/3 of the capillary volume. At the boundary between the ammonium and 
acetate buffer, as well as between the acetate and formate buffer a small amount of 
mesityl oxide (MO) was injected (20 mbar, 3 sec) to mark the location of the pH 
junctions. Voltage was then applied (20 kV) for varying lengths of time (0-10 min).
After voltage application, low pressure was used (20 mbar) to mobilize the contents of the 
capillary to the detector to visualize the enrichment.
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2.2.6 Simulation of Enrichment Using SIMUL5
The simulation computer program is available as a free download from [49]. This 
program is able to predict the movement of electrolytes during electrophoresis. For the 
purpose of this work, the run parameters were as follows: injection site, 15 mm; peak 
width 10 mm; peak edge width, 0.01 mm, EOF, 0; capillary diameter, 50 pm; capillary 
length 48.5 mm; voltage 200 V; and temperature, 25 °C. All other parameters were left at 
default values. The three buffers were simulated as follows: formate buffer, 10 mM 
formate and 0.5 mM ammonium; acetate buffer, 50 mM acetic acid and 31.74 mM 
ammonium; and ammonium buffer, 10 mM ammonium and 2.35 mM acetic acid.
2.2.7 Selective Injection and Enrichment with MALDI MS Analysis
Selective injection was performed by placing the peptide solution at the outlet end 
of the capillary (the detector end) with a buffer vial placed at the other end (inlet). The 
volume of the peptide solution was 200 pL in all experiments. To inject ACTH or the
i \
low p/peptides from the a-casein digest a positive potential (+10 kV) was applied. After 
selective injection was complete, the outlet end of the capillary (which was in the peptide 
solution) was immersed in HC1 for 2 seconds and then the selective injection buffer (50 
mM acetic acid) for 2 seconds to remove any excess peptide solution. To perform the 
enrichment step an acidic buffer (10 mM formate) was placed at the inlet and a basic 
buffer (10 mM ammonium hydroxide) at the outlet. A positive potential of +20 kV was 
applied until a sharp peak was seen at the detector (30-40 min). Once the peak passed the 
detector, the capillary was placed in a modified cassette to facilitate analysis by MALDI
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MS (Figure 2.4). The modified cassette placed one end of the capillary outside the 
instrument which allowed the contents of the capillary to be spotted onto a MALDI 
target. The contents of the capillary were deposited onto a steel MALDI target in 25 nL 
droplets (50 mbar for 15 sec). The MALDI target was pre-spotted with DHB matrix. The 
DHB matrix was used in a three-layer method for MALDI analysis [50]. Briefly, 0.5 pL 
of a 20 mg/mL DHB in methanol/acetone (1:1 v/v) solution was deposited onto the target 
followed by 0.1 pL of a 20 mg/mL DHB solution in 25 mM ammonium 
citrate/water/ethanol/phosphoric acid (60:19:20:1 v/v/v/v). After the first two layers were 
dry, the sample solution from the capillary was used as the third layer.
Figure 2.4: Schematic of spotting contents of capillary onto a MALDI target for MS 
detection.
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2.3 Results and Discussion
2.3.1 Electroosmotic Mobility
Previously in the Yeung group the phospholipids DLPC and DMPC had been use 
to suppress the EOF over a wide pH range [51-54]. However, in this work a pH of 5 
resulted in a reversed EOF which would not allow for selective injection of anions with 
the experimental setup used. Instead a suppressed forward (or cathodic) EOF was 
required for selective injection of anions at pH 5. In order to generate a suppressed 
forward EOF a negative charge must be introduced to the capillary wall. To achieve this 
a solution of DMPC and DMPA was used [1]. DMPA is similar to DMPC except instead 
of a zwitterionic group it possesses a phosphate (Figure 1.5 D). A ratio of 90:10 (mole 
ratio) yielded an average EOF of 1.62x10' cm /V-s which was found to be satisfactory 
for selective sampling at a pH of 5.
2.3.2 Evaluation of Selective Injection with UV Detection
Selective injection was evaluated using the UV-vis detector on the CE instrument. 
The sample was injected using voltage (electrokinetic injection) and then mobilized to the 
detector using low pressure. In a separate experiment, each peptide was 
hydrodynamically injected and mobilized to the detector with low pressure in order to 
obtain the absorbance of the original sample solution. Since the peptides would be 
detected at the same wavelength (200 nm), and therefore not differentiated, separate 
sample solutions were prepared and subjected to the selective sampling conditions. The
peptides chosen for this study were ACTH (MW: 2465.7 g/mol, p/4.25), AI (MW: 1296. 
g/mol, p7 7.00), and BK (MW: 1060. g/mol, p712.00). To selectively inject anions 
(ACTH), the sample was placed at the cathode. The direction of the EOF was forward 
(into the sample vial) and only negative ions would migrate into the capillary with the 
cationic peptides (AI and BK) remaining in the sample vial. Figure 2.5 A shows the 
signals detected from electrokinetic injection of the peptides. As anticipated, the only 
signal observed corresponds to ACTH. The height of the selectively injected ACTH peak 
was similar to that of the hydrodynamically injected peak (~ 6.5 mAU) which suggests 
there is little sample loss. In order to show that the cations can be selectively injected, the 
polarity of the voltage was reversed; sample placed at the anode. This resulted in the 












peptides, A) sample at cathode (10 kV, 2 min) and B) sample at anode (-10 kV, 2 
min). Mobilized to detector with -20 mbar and detected at 200 nm. Peptide
concentrations: (-----) 0.1 mg/mL ACTH, (— -) 0.15 mg/mL BK, (----- ) 0.2
mg/mL AI. Peptides were dissolved in 50 mM acetate buffer at pH 5.
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The mobility of ACTH was higher than the EOF and therefore did not migrate into the 
capillary. The peak heights of electrokinetically injected AI and BK were also close to 
the hydrodynamically injected peaks (~ 13 mAU and 8 mAU, respectively). The 
difference in the peak lengths of AI and BK can be attributed to differences of their 
mobility.
2.3.3 Evaluation of Enrichment Using UV Detection
To evaluate just the enrichment step a plug of ACTH in 50 mM pH 5 acetate 
buffer was injected between plugs of acid (10 mM pH 3 formate) and base (10 mM pH 
9.75 ammonium) buffer as shown in Figure 2.6. The theoretical p /o f ACTH is 4.25; 
therefore the peptides should be present as anions in the acetate buffer. It is anticipated 
that the anions will migrate toward the pH junction between the pH 3 and pH 5 buffers. 
The p /o f the peptides should allow them to be trapped at the pH junction as zwitterions. 
As the formate buffer titrates the acetate buffer, it is expected that the pH junction will 
migrate toward the cathode with the enriched peptides trapped at the pH junction. The 
first electropherogram (Figure 2.6 A) shows the initial setup with no voltage application. 
The subsequent electropherograms show the contents of the capillary after 2,4, 8, and 10 
minutes of voltage application (Figure 2.6 B-E).
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Figure 2.6: Electropherograms showing the enrichment of ACTH (— -) in 50 mM 
acetate buffer at various time points: A) 0 min, B) 2 min, C) 4 min, D) 8 min, and 
E) 10 min. Mesityl oxide ) marks the initial location of the pH junctions 
between the acetate buffer and 10 mM formate buffer pH 3 (right side) and 10 mM 
ammonium pH 9.75 (left side).
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After 2 min of voltage application (Figure 2.6 B) the ACTH begins to accumulate 
at the end of the sample plug; between the pH 3 and pH 5 buffers. With increasing 
voltage application time, the intensity of the peak increased (Figure 2.6 C and D). After 
10 min of voltage application the peptide peak moved out of the initial sample zone and 
the shouldering was eliminated (Figure 2.6 E) which suggests the enrichment was 
completed. At the other pH junction (between pH 5 and pH 9.75) there was some 
enrichment present. This can be attributed to the anionic ACTH peptides migrating 
slowly toward the anode. The band broadening is attributed to the use of pressure to 
mobilize the peaks past the detector.
A computer program was used to simulate the enrichment portion of the 
experiment in order to validate the enrichment method [49]. The program, called 
SIMUL5 mathematically models the migration of electrolytes during electrophoresis [55, 
56]. The program was setup as described in Section 2.2.6. The initial conditions inside 
the capillary are shown in Figure 2.7 A. The left side of the plot represents the inlet and 
is where the formate buffer is located. Next, the sample zone with the 50 mM acetate 
buffer and on the right side is the outlet with the ammonium buffer. The sample zone was 
placed closer to the inlet than performed experimentally because the peptides moved 
toward the outlet. The next three plots (Figure 2.7 B-D) show the contents of the 
capillary after 30, 240, and 600 seconds, respectfully. As the voltage application time 
increases, the sample zone decreases in size and migrates toward the outlet, which agrees 
with the experimental results. In order to get a better visualization of the changes in pH, 
just the pH was plotted at the same time points (0, 30,240, and 600 seconds, respectfully) 
in Figure 2.8 A-D. It is important to focus on the pH because its changes are responsible 
for enrichment. The simulation revealed several pieces of information about the
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enrichment step. The first is that between the pH 3 and pH 5 buffers a zone of 
electrophoretically adjusted buffer with a pH of 3.07 (Figure 2.8 B-D) and a composition 
of 62.32 mM acetic acid and 0.43 mM ammonium (Figure 2.7 B-D) is formed.
Secondly, between the pH 3 buffer and the adjusted buffer of pH 3.07 a zone of pH 3.53 
(Figure 2.8 B-D) and composition of 7.89 mM acetic acid and 0.15mM ammonium 
(Figure 2.7 B-D) is formed; this broadens with increasing voltage application time. It is 
interesting to note that this zone is created where the initial pH junction between the pH 3 
and pH 5 buffers was. The formation of these electrophoretically adjusted buffer zones is 
due to the movement of the acetate and ammonium ions toward the anode and cathode, 
respectively. Between the pH 5 and pH 9.75 buffers the pH junction remains sharp and 
no electrophoretically modified zones are created.
In the pH 3.07 buffer it is predicted the ACTH peptides would change their 
ionization (from negative to positive) and migrate as cations toward the outlet (cathode). 
Enrichment is due to the charge reversal and subsequent mobility change at the boundary 
between the pH 3.07 and pH 5 buffers. However, from the simulation data, there also 
seems to be additional stacking due to a change in conductivity. The conductivity in the 
pH 5 buffer is much higher than in the rest of the capillary (the black trace in Figure 2.7). 
The reason for the high conductivity is that the pH 5 buffer was prepared using 50 mM 
acetate. Thus when the ACTH peptides reach the boundary between the pH 3.07 and pH 
5 buffers they not only experience a charge reversal, their mobility is also decreased by 






















Figure 2.7: SIMUL5 computer simulation results of pH ( —-), conductivity (——),• formate concentration (— - ), acetate 
concentration and ammonium concentration ( — ) during enrichment at various time points: A) 0 s, B) 30 s, C) 240 s,
and D) 600 s.
<3YU\
Figure 2.8: SIMUL5 computer simulation results of pH during enrichment at various time points: A) 0 s, B) 30 s, C) 240 s, 
and D) 600 s.
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The small amount of enrichment observed at the pH junction between pH 5 and 
pH 9.75 (Figure 2.6 B-D) is due to the increase in conductivity in the pH 5 buffer. If a 
peptide moves into the pH 9.75 buffer the amount of negative charge will increase (since 
the pH is much higher than the pI) and the peptide will move back to the pH 5 buffer.
, Since the conductivity is higher in the pH 5 buffer, the ions slow down resulting in 
stacking.
The results of the simulation are similar to what was initially thought to occur 
during enrichment. The peptides in the pH 5 selective injection buffer should be 
negatively charged and therefore migrate toward the anode. The simulation revealed that 
an electrophoretically adjusted buffer would with a pH of 3.07 which would alter the 
ionization state of the peptides once they migrated out of the pH 5 buffer. The peptides, 
now cations, would then change direction and migrate toward the cathode and become 
enriched at the pH junction between the pH 3.07 and pH 5 buffers. In addition to pH 
mediated stacking, the pH 5 buffer had a much higher conductivity than the rest of the 
buffers. Resulting in field amplified stacking as well since the peptides would have a 
higher mobility in the pH 3.07 buffer than in the pH 5 buffer.
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2.3.4 Combining Selective Sampling and Enrichment with MALDI MS Analysis
To evaluate the integrated procedure of selective sampling and enrichment using 
two pH junctions, a solution of ACTH, AI, and BK was used. The sample solution was 
placed at the outlet (peptides in 50 mM acetate buffer, pH 5) and selective injection was 
performed (10 kV, 5 min) then a formate buffer (10 mM formic acid, pH 3) vial was 
placed at the inlet and an ammonium buffer (10 mM ammonium, pH 9.75) vial was 
placed at the outlet. Voltage was applied (20 kV, 30 min) to enrich the peptides. After 
30 min of voltage application low pressure (20 mbar) was used to mobilize the peak to the 
detector. The electropherogram of the enrichment portion of the experiment is shown in 
Figure 2.9 with the sharp peak anticipated to be enriched ACTH.
Figure 2.9: Electropherogram of selective injection coupled to enrichment of 
a solution of 0.05 mg/mL ACTH, AI, and BK in 50 mM acetate at pH 5. 
Experimental conditions: selective injection 5 min 10 kV followed by 20 kV 
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Figure 2.10: MALDI MS spectra of A) the original sample mixture injected and 
spotted hydrodynamically and B) the 11th MALDI spot of the integrated procedure, 
Conditions: sample placed at cathode and selective injection performed (10 kV, 5 
min) followed by enrichment (20 kV, 30 min, then 20 mbar); ACTH, AI, and BK 
concentration: 0.05 mg/mL; MS: reflectron and positive ion mode, 25 nL spot 
volumes.
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The results of MS analysis of the sharp peak seen in the electropherogram are 
shown in Figure 2.10 A-B. Even though there were some of the unwanted peptides 
present in the MALDI spectra, the ACTH was enriched (Figure 2.10 A-B). The average 
peak height of ACTH before enrichment was 3100 and after it was 9500, leading to an 
enrichment factor of 3. The enriched ACTH was spread over two main spots (data not 
shown) with subsequent spots having lower and lower intensities. It was hoped that the 
small spot volume (25 nL) would enable the enriched peptide to be contained in a single 
MALDI spot. Broadening due to the use of pressure to spot onto the MALDI target and 
the difficulty of capturing the enriched peptide in a single spot contributed to the peak 
being spread over two spots.
While the selective injection was successful in keeping the bradykinin from 
entering the capillary it appears that some AI was present in the spots with ACTH. Since 
the selective sampling step was performed at the same end of the capillary as spotting, it 
is possible that some of the peptides adsorbed onto the outside of the capillary and were 
deposited onto the MALDI target during spotting. It was for this reason that the outlet of 
the capillary was submerged in a vial of acid (0.1 M HC1) and then buffer (50 mM 




Through the use of UV-Vis detection it has been shown that selective injection is 
successful in allowing the migration of the desired anions into a capillary. The results 
agreed with what had been previously reported [54]. The enrichment of the ACTH 
peptides was then investigated using UV-Vis detection and enrichment was observed 
within 10 minutes of voltage application.
A simulation program was used to model the enrichment portion of the 
experiment. It was found that two electrophoretically altered buffer zones were created 
with voltage application due to the movement of the buffer ions. One formed inside the 
sample zone and had a pH of 3.07 and was composed of 62.32 mM acetic acid and 0.43 
mM ammonium. The other zone formed at the initial location of the pH junction between 
the pH 3 and pH 5 buffers. This electrophoretically generated buffer had a pH of 3.53 
and was composed of 7.89 mM acetic acid and 0.15 mM ammonium. The enrichment 
step was found to occur in a similar way to what was initially thought. The ACTH 
peptides (p/4.25) would be negatively charged in the pH 5 selective injection buffer and 
migrate toward the anode. Once they crossed the pH junction between the pH 5 and pH
3.07 buffers they would become cations and reverse direction toward the cathode. The 
enrichment would be due to the charge reversal at the pH junction between pH 5 and pH 
3.07. The simulation also revealed stacking due to a change in conductivity. The initial 
buffer which the peptides were in (50 mM acetate pH 5) had a high conductivity while the 
pH 3.07 buffer had a relatively low conductivity. Thus, any peptides which were in the 
pH 3.07 buffer would experience a drop in mobility at the boundary between the pH 3.07 
and pH 5 buffers.
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The integrated method of selective sampling and enrichment yielded promising 
results when it was tested with a peptide mixture of ACTH, AI and BK. This technique is 
ready to be tested with phosphorylated peptides. A possible first choice would be to use a 
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Protein phosphorylation is one of the most common post-translational 
modifications and is involved in many cellular signaling and regulatory mechanisms [1]. 
However, detection of phosphorylated peptides by MS is relatively challenging, not only 
due to their low abundance but also due to ion suppression from non-phosphorylated 
peptides. As mentioned in Chapter 2, there has been considerable effort in enhancing the 
signal of phosphopeptides in MS. This has included additives to the MALDI matrix such 
as ammonium salts and phosphoric acid [2-5]. Another approach was to chemically 
modify the phosphate group to increase ionization efficiency [6]. In addition to 
increasing the detection of phosphorylated peptides there has been a need to isolate 
phosphorylated peptides from other non-phosphorylated peptides in the sample. Most of 
the techniques involve sorption where the phosphate shows some affinity for the 
stationary phase and becomes bound temporarily. The unwanted peptides pass through 
the column then the phosphorylated peptides are released and collected. The most 
commonly used methods are immobilized metal affinity chromatography and metal oxide 
affinity chromatography [7-12].
Immobilized metals are used to selectively retain phosphorylated peptides, but this 
method suffers from non-specific binding of carboxylate groups from acidic amino acid 
residues. One method to solve this problem is to esterify the carboxylate groups on all 
peptides including aspartate and glutamate and the C-terminus. This is known to reduce 
non-specific binding of non-phosphorylated peptides on immobilized metal.
Mass spectrometry has emerged as an indispensable tool in proteomics. Its high 
sensitivity, low detection limits, and label-free detection technique make it an excellent
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tool for analysis of proteins and peptides. While MS analysis requires sub-pL sample 
volumes and is able to detect very small quantities of sample (less than an attomole), 
traditional sample handling, purification, and concentration techniques are limited to 
relatively large volumes of samples (mL to pL). This imposes an unnecessary increase in 
sample requirement for the total analysis, including sample handling. An effective way to 
downsize the handling steps therefore becomes especially important. Miniaturization of 
the sample concentration steps also has the benefit of increasing the sensitivity in MS 
detection. The need for miniaturization has led to the development of microfluidics and 
ultimately lab-on-a-chip devices.
Microfluidics presents the logical choice for the manipulation of very small 
volumes; usually in the range of nanoliters (nL) down to femtoliters (fL) and even 
attoliters (aL) [13]. These small volumes are controlled using pumps, valves, and 
electrodes which allow for mixing, separation, and digestion to be performed in the micro 
channels. One of the main advantages of microfluidic devices is the reduced sample, 
reagent, and solvent used which in turn reduces the amount of waste produced, relative to 
a full-scale instrument. Another advantage is if several steps in an analysis were 
performed on a single microfluidic device; for example concentration of the sample, 
separation, and then detection using MS. The amount of sample handling would be 
greatly reduced allowing for more reproducible results, less sample loss due to adsorption 
and contamination during sample handling. As more of the analysis becomes integrated 
on a microfluidic device, to the point where the entire analysis can be performed, the term 
lab-on-a-chip (LOC) can be used. Commercially available fully integrated LOC do not 
yet exist for proteomics. Most of the research in the area of microfluidics and LOC for 
proteomics has been into the development of single function chips and interfacing to MS.
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Fully integrated LOC devices are still in the early stages of development with research 
still to be done before this technique becomes more widely used. LOC devices also have 
to compete with traditional, well established instruments and techniques. A switch from 
traditional methods to microfluidics and LOC devices would require a significant 
advantage and/or lower costs. As mentioned above, most of the research has been 
focused on single function chips coupled to MS detection; the single function is usually a 
separation. This leaves the difficult task of integrating sample derivatization and/or 
concentration onto a chip along with separation and detection.
In many cases a full scale instrument is used to develop methods for 
miniaturization. Capillary electrophoresis (CE) is an appropriate technique to investigate 
method development for LOC and microfluidic devices. Some of the attractive features 
of CE for miniaturization are: low volumes inside the capillary, samples can be 
manipulated with either pressure or voltage, many techniques exist for concentration, and 
the instrument can be coupled with MS detection. Several separation modes and 
concentration methods used in CE have already been scaled down for use on microfluidic 
devices [14-18]. While CE has been used extensively as a separation technique, it is also 
well suited for sample preparation.
Yeung’s group has focused mainly on sample preparation studies performed in 
aqueous media. There are some sample preparations which must be performed in non- 
aqueous conditions. Sample preparation in-capillary under non-aqueous conditions has 
been very limited. There are a few publications which use large volume sample stacking 
(LYSS) which was developed in aqueous CE [19]. This concentration method has been 
used in non-aqueous conditions to concentrate parabens and p-hydroxybenzoic acids with 
sensitivities in the ng/mL range [20,21]. The work presented here are efforts toward in-
J
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capillary methyl esterification of phosphopeptides in non-aqueous conditions. A general 
réaction scheme is shown below in Figure 3.1.
MeOH HC1
HC1 +  MeOH
O
+  HC1
Figure 3.1: Schematic showing the general methyl esterification reaction. The 
top reaction shows the formation of anhydrous HC1 in methanol. The bottom 
reaction shows the methyl esterification of a generic carboxylic acid.
Performing the methyl esterification reaction in-capillary would have the 
advantage of consuming a small amount of peptide sample, aiding in the miniaturization 
of the reaction. In addition, once inside the capillary and esterified, the CE instrument 
could then be coupled to MALDI MS for detection. The two main types of MS ionization 
used in proteomics are matrix assisted laser desorption/ionization (MALDI) and 
electrospray ionization (ESI) because their ionization mechanism is ‘soft’ and does not 
extensively fragment proteins and peptides. In general, MALDI is used over ESI in CE 
and there are several reasons but the main ones are: the ease of coupling to the instrument 
and being able to spot a portion of the volume inside a capillary.
The work presented here aims to investigate and hopefully resolve a number of 
challenges associated with in-capillary methyl esterification. The first challenge is the
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extremely acidic reaction conditions which can potentially damage the instrument 
components. It may also generate exceedingly high current when voltage is applied. A 1 
second challenge is that the reaction must be performed in a water-free environment due 
to side product formation. The solvent used in the reaction is methanol and it readily 
absorbs water from the atmosphere so extra care must be taken to ensure minimal water 
contamination. Additionally, since the reaction must be performed in non-aqueous 
conditions the capillary wall cannot be coated. Many coatings are extremely sensitive to 
the presence of organic solvents and are often severely degraded if not completely 
removed from the capillary wall. With these challenges in mind, the reaction will first be 
performed in the traditional way of in-vial. In order to determine the compatibility of the 
CE instrument with the reaction conditions, the reactants will be mixed prior to being 
injected into a capillary and then allowed to react. The length of time required for the 
reaction to proceed as well as the sensitivity of the reaction will then be investigated. The 
advantages of in-capillary reaction over conventional in-vial reactions will be carefully 
examined. Once this has been established, performing the reaction in-capillary will be 
investigated by using various sample introduction and mixing techniques. The findings 
will determine future directions in manipulating the migration (introducing and removal) 




All measurements of methanolic-HCl solutions in an applied electric field were 
performed on a Beckman Coulter P/ACE MDQ Capillary Electrophoresis Instrument 
(Fullerton, CA, USA) and all in-capillary reactions without voltage application and 
spotting from capillary onto a MALDI target were performed with an Agilent 3D-CE 
Capillary Electrophoresis Instrument (Palo Alto, CA, USA). Data acquisition was 
performed using the Beckman P/ACE System MDQ software or ChemStation software 
by Agilent. Uncoated fused-silica capillaries were purchased from Polymicro 
Technologies (Phoenix, AZ, USA). The capillary dimensions were 50 pm in inner 
diameter, 360 pm in outer diameter with a total length of 50 or 40 cm, and the detection 
window at 40 or 30 cm, respectively, from the inlet. During runs, capillaries were 
thermostated at 25 °C. Mass spectrometry data was obtained using a Bruker Reflex IV 
MALDI Time-of-Flight (TOF) mass spectrometer (Bremen/Leipzig, Germany). The 
instrument was equipped with a 3 ns 337 nm nitrogen laser. Reflection and positive ion 
mode were used. Igor Pro (WaveMetrics, Lake Oswego, OR, USA) was used for data 
processing.
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3.2.2 Chemicals and Reagents
Anhydrous methanol was purchased from Sigma Aldrich (St. Louis, MO, USA) 
and was used in methyl esterification reactions and voltage tests. Acetyl chloride was 
purchased from Fluka and was used as a source of protons in the methyl esterification 
reaction. Angiotensin IF (Sigma Aldrich) was used as a model peptide due to its low cost 
and two possible sites of methyl esterification. 2,5 dihydroxybenzoic acid (DHB) (Sigma 
Aldrich) was used as the matrix for MALDI. Water was deionized by a Millipore 
purification system (Bedford, MA, USA). Myoglobin (horse heart) was obtained from 
Sigma Aldrich.
3.2.3 Capillary Preconditioning
Prior to use, a new capillary was flushed (1 bar) with anhydrous methanol for 30 
min. The typical capillary pre-treatment of flushing the capillary with sodium hydroxide, 
water, coating (if applicable), and running buffer was not employed due to the presence of 
water in these solutions. Any water present during methyl esterification would lead to 
formation of side products. Between runs, the capillary was flushed with anhydrous 
methanol for at least 30 min. After use, the capillary was flushed with anhydrous 
methanol for 30 min and stored with the ends of the capillary in vials of methanol.
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3.2.4 Methyl Esterification
The methanolic-HCI solution was prepared using a literature procedure [22]. In 
short, 160 pL of acetyl chloride was added drop-wise to 1 mL of anhydrous methanol. 
The reaction was allowed to stir for 5 min at room temperature before being used. When 
larger volumes of methanolic-HCI were needed, this procedure was scaled up, 
maintaining the same acetyl chloride to anhydrous methanol ratio. Fresh solutions of 
methanolic-HCI were prepared each day.
3.2.4.1 In-Vial Methyl Esterification
In-vial reactions were performed by adding methanolic-HCI to angiotensin II 
(All) dried (SpeedVac) in a 0.6 mL PCR vial. The vial was then capped and the reaction
i
allowed to proceed at room temperature for the desired length of time. Once the reaction 
time was reached, the reaction mixture was evaporated using a SpeedVac. The peptides 
were then reconstituted in water and spotted on double-layered DHB spots for MALDI 
MS analysis and comparison to in-capillary reactions.
3.2.4.2. In-Capillary Methyl Esterification
The in-capillary reactions using the Agilent instrument was performed in the same 
way as the first step in 3.2.4.1 (methanolic-HCI was added to a vial containing All). The 
reaction mixture was then injected into a capillary using low pressure (50 mbar) for 10 
min. Since the reaction mixture was very acidic, injection had to be performed from
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outside the CE instrument to avoid damage to the electrodes and interior of the 
instrument. The setup was similar to that used for spotting the products on a MALDI 
target as shown in Figure 3.4. Instead of the MALDI target at the outlet, the vial of 
reaction mixture was placed on a riser, which was at the same level as the inlet end of the 
capillary, and vacuum was used to inject some reaction mixture into the capillary. Once 
injection was complete, the capillary was returned to the cassette and placed in the 
instrument for the duration of the reaction with the ends of the capillary in methanol vials. 
After the reaction time was reached, the contents of the capillary were spotted onto 
double-layered DHB matrix for MALDI MS analysis and comparison to in-vial methyl 
esterification.
3.2.5 Performing Reactant Mixing Inside a Capillary
The mixing of reactants inside the capillary was performed using the Beckman 
P/ACE CE instrument. The capillary was first flushed (1 bar) for 30 minutes with
anhydrous methanol to remove and traces of water from inside the capillary. After the
\
MeOH-HCl was prepared, it was flushed (1 bar) through the capillary for 30 minutes. To 
mix the reactants, the capillary was first filled with MeOH-HCl and then a short plug of 
peptide dissolved in methanol (15 s, 20 mbar) was injected followed by MeOH-HCl (15 s, 
20 mbar). This sequence was repeated until there were ten plugs each of MeOH-HCl and 
peptide. The set of plugs was then mobilized to the centre of the capillary with low 
pressure. When voltage was used to mix, positive polarity voltage was applied for 1 
minute then negative polarity voltage was applied for 1 minute. This swapping of voltage 
polarity was repeated 28 times. When pressure was used to mix the plugs, positive
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pressure and vacuum were alternated to afford mixing 28 times. Once the mixing was 
finished, the reaction was allowed to proceed for one hour. After one hour, the capillary 
was removed from the Beckman instrument and transferred to an Agilent CE instrument 
for spotting onto a MALDI target (discussed below).
3.2.6 MALDI Conditions and Spotting from Capillary
Detection of the reaction products from in-capillary reactions was performed by 
direct spotting of the contents of the capillary onto a MALDI target in 0.2 pL fractions, 
using a matrix of layered DHB, with MALDI MS detection in TOF-R mode. A 
schematic of this method is shown in Figure 3.2. Briefly, once the reaction is complete, 
the outlet is placed outside the instrument and low pressure was used to mobilize the 
product toward the outlet where it was spotted onto the MALDI target. The DHB was 
prepared from a literature procedure and applied to the MALDI target in two layers (0.5 
pL base layer, and 0.2 to 0.05 pL top layer, then sample) [23]. Calibration was 
performed using an in-house tryptic digest of Myoglobin (horse heart). Detection of 
esterification products was limited to ions between 300 and 4000 m/z. Each MS 
spectrum shown is a sum of 100 laser shots, unless otherwise noted.
CE instrument
Figure 3.2: Schematic of spotting contents of capillary onto a MALDI target for 
MS detection.
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3.3 Results and Discussion
3.3.1 Degree of Methyl Esterification with Varying Reaction Times
The length of time it takes the reaction to go to completion was investigated.
Some procedures reported conversion to fully esterified product in less than an hour with 
side product and sample degradation occurring with longer reaction times [24], Others 
reported longer reactions sometimes followed by evaporation of the reaction mixture and 
repeating the reaction [25,26]. The difference in reaction times is likely due to the 
number of carboxyl groups in the starting material. Peptides with only a few sites for 
esterification take less time to fully esterify while peptides which are larger and have 
more possible sites for esterification take more time and potentially several rounds of 
esterification.
For the initial experiments a model peptide was chosen instead of using a 
phosphorylated protein digest. The peptide chosen was angiotensin II (All) due to its low 
cost and the presence of two esterification sites.
3.3.1.1. In-Vial Reaction Time
The in-vial reaction was performed by adding MeOH-HCl to dried angiotensin II. 
The contents of the vial were then shaken and allowed to react for various amounts of 
time. Once the reaction time was reached, the MeOH-HCl was removed (lyophilized) 
and the subsequent dry peptides were re-constituted in water prior to MS analysis. The 
in-vial reaction times are shown in Figure 3.3. The peaks present after the labeled peak 
in the figures represent the isotopic distribution of AIL The labeled peak shows the
monoisotopic peak. In this figure, the uppermost MS spectrum shows the starting 
material, angiotensin II (All), before the addition of methanolic-HCl. The only peak 
present corresponds to un-esterified All at 1046 m /z.A  peak at 1060 m/z represents 
singly esterified All and a peak at 1074 m/z corresponds to doubly (fully) esterified All. 
The progression of the reaction was observed every twenty minutes for one hour and then 
once more after four hours.
Figure 3.3: Mass spectra of the in-vial reaction mixture under various reaction times. 
The sequence of All is shown and the bold purple denotes esterified amino acids. 
Conditions: 50 pL of MeOH-HCl added to vial of dried peptides. Reaction proceeded 
for the desired length of time then spotted on MALDI target.
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The reaction proceeds quickly, after twenty minutes there was no starting material 
and a large peak representing the full esterification of All appeared. It appears that after 
one hour the reaction has gone to completion with longer reaction times showing the 
reappearance of single ester. Since the reaction is reversible and water is a side product 
of the reaction, it is possible that the generation of water during the reaction is responsible 
for the small amount of single ester reforming.
The short reaction time for most of the peptide to become fully esterified may be 
attributed to the peptide’s small size (8 amino acids) and having only two possible sites 
for esterification. When this work is extended to more complex samples the reaction time 
may need to be adjusted. However, for work with All, a reaction time of one hour will be 
used for all subsequent in-vial reactions.
3.3.1.2 In-Capillary Reaction Time
The set-up for the in-capillary reaction was different than for the in-vial method. 
The procedure started out the same way: MeOH-HCl was added to dry angiotensin II and 
then shaken. Next, the reaction mixture was injected into a capillary using pressure. The 
reaction was allowed to proceed and then the contents of the capillary were spotted 
directly onto a MALDI target for MS analysis. Since there was some time required for 
the reaction mixture to be injected into the capillary, it was difficult to obtain short 
reaction times, for this reason the shortest reaction time was half an hour. The mass 
spectra in Figure 3.4 show the results from different reaction times performed in­
capillary.
Figure 3.4: Mass spectra of in-capillary reaction mixtures over various reaction 
times. The sequence of All is shown and the bold purple denotes esterified amino 
acids. Conditions: 50 pL of MeOH-HCl was added to a vial of dried peptides. The 
reaction mixture was then injected into a capillary. Once desired reaction time had 
elapsed the contents of the capillary were spotted onto a MALDI target for MS 
analysis. ■'
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The uppermost mass spectrum shows the starting material (1046 m/z). There is 
very little starting material present after half an hour and most of the All has been fully 
esterified. After one hour of reaction, there appears to be no remaining starting material 
and a very small amount of singly esterified product present with the majority being fully 
esterified. Reaction times of two and four hours do not show an increase in fully 
esterified AIL The in-capillary method appears to follow the same trend as the in-vial 
method.
There appears to be less formation of singly esterified peptide formed in-capillary 
than with the in-vial method. A plausible explanation is that when the reaction is 
performed in-capillary the reaction mixture does not come into contact with as much 
water from the air because the ends of the capillary are placed in vials of methanol for the 
duration of the reaction. In an attempt to remove any water present in the capillary it was 
flushed with methanol for at least 30 minutes prior to injection of the reaction mixture. 
The in-capillary method allows for spotting of the reaction mixture directly from the 
capillary onto a MALDI target.
An advantage to performing the reaction inside a capillary is that the reaction 
mixture does not need to be removed prior to MS analysis. This is because the spot 
volume with the in-capillary method (50 nL) was much smaller than with the in-vial 
method (0.25 pL). With a smaller spot volume, there was less spreading of the MeOH- 
HC1 and MS spectra could be collected. When the reaction mixture was spotted using a 
pipette (0.25 pL) the pre-spotted matrix was dissolved and it was impossible to obtain MS
data.
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3.3.2 Degree of Methyl Esterification with Varying All Concentration
The reaction was first attempted using a high concentration of AIL The 
concentration of All was then decreased to get an idea of the sensitivity. Three 
concentrations of All were chosen to be tested 2.0, 0.2, and 0.02 pg/mL. The reaction 
was performed at each concentration both in-vial and in-capillary with a one hour 
reaction time.
The mass spectra of the results using 2.0 pg/mL are shown in Figure 3.5. The left 
mass spectrum shows the reaction products in-capillary and the right mass spectrum 
shows the in-vial products. This concentration yielded high intensity peaks and a very 
good signal-to-noise ratio (S/N).
1074
m/z
Figure 3.5: Mass spectra of in-capillary and in-vial methyl esterification 
of 2.0 pg/mL AIL
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The next concentration of AITtested was 0.2 pg/mL. The mass spectra of the 
results are shown in Figure 3.6, with the in-capillary method on the left and the in-vial on 
the right. The intensities are much lower than with the previous concentration but the S/N 
is still high.
1074
3500 -i In-Capillary ^ 3500 —i In-Vial
3000- 3000-
1074
.  2500 - 2500 - 1
g  2000 - 2000 -j
<3
£  1500- 1500 -
1000 - 1000-1
50 0 - 1 500 - 1
o - \ -------- L-------- 1------ ---------- 1---- l 1 ...
1040 1050 1060 1070 1080 1090 1040 1050 1060 1070 1080 1090
m/z
Figure 3.6: Mass spectra of in-capillary and in-vial methyl esterification 
of 0.2 pg/mL AIL
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The mass spectra in Figure 3.7 show results from the in-capillary and in-vial 
methods with 0.02 pg/mL of AIL The most obvious difference between the two spectra 
is that there are no peaks present with the in-vial method. The most probable explanation 
for this is that when using such a low concentration of peptide there is significant 
adsorption to the sides of the vial. Even though the vials used were designed to reduce 
the adsorption of sample, it still occurs to some degree. A second possibility is that there 
is some sample loss/degradation of the peptides during the lyophilization step when the 
in-vial method is used.
1074
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Figure 3.7: Mass spectra of in-capillary and in-vial methyl esterification 
of 0.02 pg/mL AIL
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Another possibility is the sample was not found when MALDI analysis was 
performed. This is one of the disadvantages of using MALDI MS, samples can 
congregate in ‘hot spots’ that are sometimes difficult to find. Another disadvantage of 
using MALDI is for the analysis of small amounts of sample: the matrix spots are usually 
quite large and finding the sample can be tedious. A solution to this is to prepare matrix 
spots that are very small so the area for the sample to be deposited is much smaller. It is 
because of these disadvantages that this particular amount of reactant was run several 
more times than the other amounts. In all of the runs performed, there were no peaks 
seen for the in-vial method.
One of the trends apparent in all three of the concentrations used was that the in­
capillary method consistently had higher intensity peaks. In the case of the lowest 
concentration of All used (0.02 pg/mL) there were no peaks seen when the reaction was 
performed in-vial. Here we find another advantage to using the capillary as a reaction 
vessel: a lower limit of detection is achieved.
i
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3.3.3 Performing the Methyl Esterification Reaction Inside a Capillary
Up until this point the reactants were mixed prior to injection into a capillary 
essentially using the capillary as a small vial. Since there were advantages to performing 
the reaction inside a capillary, the next step was to investigate methods of mixing the 
peptide with the MeOH-HCl inside a capillary. It was determined the best way to 
introduce the peptides and MeOH-HCl would be to have the capillary filled with MeOH- 
HC1 and then inject the peptides. The two could then be mixed using either voltage or 
pressure. Injecting a large plug of peptide into the MeOH-HCl would probably not result 
in a complete reaction. So, the peptides and MeOH-HCl were injected in alternating 








Figure 3.8: Schematic of in-capillary reaction with alternating bands of methanolic- 




3.3.3.1 Using Voltage to Mix the Peptide and MeOH-HCl
Mixing the peptide and MeOH-HCl was first tried using voltage. The peptides 
dissolved in methanol and the MeOH-HCl were injected into a capillary in alternating 
plugs as depicted in Figure 3.8. Since applying only one polarity of voltage would move 
everything out of the capillary, positive and negative polarity voltage was applied for 1 
minute and then switched to the opposite polarity; this switching was repeated 14 times. 
The reaction was then allowed to proceed for one hour and then the contents of the 
capillary spotted onto a MALDI target. There were peptides present in four consecutive 





Figure 3.9: MALDI mass spectra of the four consecutive spots (A, B, C, D) from mixing the reactants inside a capillary 
using voltage. The peak at 1046 m/z is starting material (All); 1060 m/z represents a peptide with a single ester; and 1074 m/z 
represents a peptide which has been fully esterified. Conditions: 50 nL was spotted onto MALDI target pre-spotted with 
DHB. Each spectrum is a sum of 100 individual shots oo
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The MS data show that using voltage to mix was not able to afford successful mixing of 
the reactant plugs. It is possible that the high current generated during voltage application 
did not allow the protons to migrate very fast. If this was the case, then they would not 
penetrate very far into the peptide band. Since using voltage was not successful in 
successful mixing using pressure to mix the reactants was investigated.
3.3.3.2 Using Pressure to Mix the Peptides and MeOH-HCl
The next option would be to use pressure to mix the peptides with the MeOH- 
HC1. The setup was the same as when voltage was used for mixing. In the same way the 
polarity of the voltage was alternated, the pressure was switched between pressure and 
vacuum to mix the bands together. There were peptides present in four consecutive 
MALDI spots and the results are shown in Figure 3.10 A-D. From the MS spectra it 






Figure 3.10: MALDI mass spectra of the four consecutive spots (A, B, C, D) from mixing the reactants inside a capillary 
using pressure. The peak at 1046 m/z is starting material (All); 1060 m/z represents a peptide with a single ester; and 1074 
m/z represents a peptide which has been folly esterified. Conditions: 50 nL was spotted onto MALDI target pre-spotted with 
DHB. Each suectrum is a sum of 100 individual shots oto
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From the MS data, the mixing methods used were not successful. It was hoped that by 
alternating the injection of peptide and MeOH-HCl bands better mixing would be 
achieved. Even after a reaction time of 1.5 hours (mixing + 1 hour reaction time) there 
was still starting material left. It is difficult to determine causes for the poor mixing of 
the reactants. One possible reason is that the amount of voltage used (when voltage was 
used to mix) was not enough to allow the protons to migrate into the peptide plugs. Since 
there was such a high concentration of HC1 the voltage was limited due to the high 
current generated.
It is unlikely the methanol used to dissolve the peptides contributed to dilution of 
the MeOH-HCl. To prepare the MeOH-HCl, 160 pL of acetyl chloride was added to 
1000 pL of methanol. Therefore the addition of several more nanoliters of methanol 
would not likely have a major effect on the concentration of the anhydrous HC1.
Another possibility is the dimensions of the capillary. With such a small i.d. (50 pm) 
there simply may not have been enough room for effective mixing to take place. A 
potential remedy for this would be to use a capillary with a larger i.d. however this would 
make spotting onto MALDI target difficult. By using a larger i.d. it would be more 
difficult to spot a small volume and when methanol is spotted onto a MALDI target it 
spreads out quite a bit. Even spotting a volume of 50 nL of methanol from a 50 pm i.d. 
capillary produces a much larger spot than the same volume of water. The other problem 
with spotting methanol is that if too much is spotted, it will dissolve the two layers of 
matrix already deposited on the target. The result is that the matrix becomes so thin that 
is becomes impossible to generate any data.
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3.4 Conclusions
Testing the reaction in-vial and in-capillary revealed two advantages of the in­
capillary method over the in-vial. The first is that removal of the MeOH-HCl prior to 
spotting on a MALDI target was not required for the in-capillary method; the reaction 
mixture can be spotted directly from the capillary onto the MALDI target. The reason for 
this is the spot volume was much smaller when using a capillary (50 nL) than with a 
pipette for the in-vial method (0.25 pL). The smaller spot volume did not completely 
dissolve the pre-spotted matrix and allowed for MS analysis. With the in-vial method, the 
larger spot volume essentially dissolved the pre-spotted matrix and made MS analysis 
impossible. Therefore, the MeOH-HCl had to be removed and the peptides reconstituted 
in water to obtain MS data. The second advantage was that a lower detection limit was 
achieved with the in-capillary method. The most likely explanation for this is that during 
lyophilization some of the peptides were lost and/or degraded. Since the in-capillary 
method did not require lyophilization, there was less sample loss.
Thè in-capillary method was used to gauge the effectiveness of the capillary as a 
reaction vessel. There was no voltage used in the experiments. Since there were 
advantages to performing the reaction in-capillary, mixing the reactants inside the 
capillary was investigated. The peptide and MeOH-HCl were injected in alternating 
bands in an attempt to facilitate their mixing. Two mixing methods were examined: 
mixing with voltage and mixing with pressure. It turned out that using either voltage or 
pressure was not effective in mixing the reactants. Since the goal was to utilize the 
capabilities of the CE instrument (use voltage to manipulate the sample) the project was 
left at this point and not investigated further.
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Over the past decade or so mass spectrometry has been the detection method of 
choice for protein and peptide identification due to its label-free detection, user 
friendliness and high throughput capabilities. However, low abundance peptides often 
have their signals suppressed by those with higher abundances. It is for this reason that 
sample purification and preconcentration steps prior to MS analysis have become 
important. Since the acidic phosphate group on phosphorylated peptides reduces 
ionization efficiency, these sample preparation steps prior to MS analysis are especially 
important. This thesis investigated two different techniques related to the analysis of 
phosphorylated peptides. While they focused on different sample pretreatments the 
general goal was to improve the signal intensity of the desired analytes.
Integration of selective sampling of peptides based on pI  followed by enrichment 
using a pH junction was attempted. The use of a phospholipid surfactant to coat the 
capillary was essential to allow for selective sampling under the chosen conditions. A 
computer program was used to simulate the enrichment portion of the experiment. It wasA
discovered that enrichment was achieved by both pH mediated and field amplified 
stacking. Integrating selective injection and enrichment was successful in selecting and 
enriching an acidic peptide from a mixture.
The miniaturization of a methyl esterification reaction was also attempted. 
Preliminary experiments using a capillary as a reaction vessel were promising. It was 
found that mixing the reactants together and then injecting them into a capillary had 
advantages over the traditional in-vial method: lyophilization of the MeOH-HCl was not 
required and a lower detection limit was achieved. However, when mixing the reactants
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inside a capillary was attempted using both voltage and pressure, there was not sufficient 
mixing to allow for a complete reaction to take place; One of the goals of this project was 
to use electrophoresis to manipulate the reactants. Since mixing with voltage was not 
successful there was no further investigation in this project.
4.2 Future Work
The next step in the integrated procedure of selective sample injection and 
enrichment would be to use the method on a phosphorylated peptide sample. If 
successful with phosphorylated peptides it would be interesting to see if the method could 
be applied to other post translational modifications where there is a change in p/when the 
PTM is added. An example of such is the sulfation of tyrosine, threonine, and serine 
amino acid residues [1-3]. Similar to phosphorylation, sulfation lowers the p/ of the 
peptide due to its acidic nature [4, 5]. It has been found that this modification has been 
present at sites where protein-protein interactions take place as well as affecting many 
other biological functions which has greatly increased interest in studying this PTM [6]. 
Due to the p7 change when the sulfate group is added to the peptide, it should be possible 
to selectively sample the sulfated peptides. With the correct selection of buffers the 
enrichment should also be feasible.
There are some ideas to try with the methyl esterification reaction. One would be 
to decrease the size of the sample and MeOH-HCl plugs. This would hopefully allow for 
complete mixing of the two reactants. Another idea would be to continually switch the 
polarity of the voltage for the duration of the reaction. Once the conditions were 
optimized, the reaction could be tested on digest of a phosphorylated protein.
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One of the main advantages of using CE techniques over traditional 
chromatographic techniques is its use of voltage. This is especially true when adapting 
techniques for use on microfluidic devices. Voltage driven techniques are desired over 
pressure techniques since there would be no need for pumps. It is hoped that the sample 
preparation and separation techniques developed by Yeung’s group will be miniaturized 
and integrated onto a microfluidic device. In recent years there has been intensive 
research into coupling micro fluid devices to MS [7, 8] and progress toward lab-on-a-chip 
[9-11]. Continued efforts from Yeung’s group as well as many other researchers are 
required to realize the goal of a lab-on-a-chip to analyze an entire proteome.
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